190 related articles for article (PubMed ID: 32468032)
1. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling.
Zhang S; Yang Y; Hua Y; Hu C; Zhong Y
Mol Med Rep; 2020 Aug; 22(2):774-782. PubMed ID: 32468032
[TBL] [Abstract][Full Text] [Related]
2. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
Zhang QY; Yue XQ; Jiang YP; Han T; Xin HL
Sci Rep; 2017 Mar; 7(1):396. PubMed ID: 28341836
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Wan XY; Zhai XF; Jiang YP; Han T; Zhang QY; Xin HL
Am J Transl Res; 2017; 9(1):155-166. PubMed ID: 28123642
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
Huang S; Tuergong G; Zhu H; Wang X; Weng G; Ren Y
Acta Pharm; 2021 Jun; 71(2):267-278. PubMed ID: 33151174
[TBL] [Abstract][Full Text] [Related]
7. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
9. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q
Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin Enhances High Concentrations of Fetal Bovine Serum-Induced Apoptosis in Human Mesangial Cells by Regulating the Mitogen-Activated Protein Kinase Signaling Pathway.
Ye K; Wei QY; Long TX; He HG; Huang YF; Xiong LJ; Lan J; Huang YY; Gong ZF; Peng XM; Wu QX
Kidney Blood Press Res; 2019; 44(6):1339-1351. PubMed ID: 31661692
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
Peng C; Li Z; Niu Z; Niu W; Xu Z; Gao H; Niu W; Wang J; He Z; Gao C; Lin P; Agrez M; Zhang Z; Niu J
Sci Rep; 2016 Feb; 6():20500. PubMed ID: 26846153
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.
Liao HF; Chen YJ; Chou CH; Wang FW; Kuo CD
Toxicol In Vitro; 2011 Feb; 25(1):206-12. PubMed ID: 21075198
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
Liao HF; Su SL; Chen YJ; Chou CH; Kuo CD
Food Chem Toxicol; 2007 Sep; 45(9):1678-87. PubMed ID: 17442474
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
Chen AW; Tseng YS; Lin CC; Hsi YT; Lo YS; Chuang YC; Lin SH; Yu CY; Hsieh MJ; Chen MK
Environ Toxicol; 2018 Mar; 33(3):343-350. PubMed ID: 29193574
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
He Q; Xue S; Tan Y; Zhang L; Shao Q; Xing L; Li Y; Xiang T; Luo X; Ren G
Cancer Lett; 2019 Apr; 448():94-104. PubMed ID: 30742942
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
